Researchers develop telehealth-based rehab system
MUNICH – The Fraunhofer Institute for Open Communication System has developed a telehealth-based exercise therapy for artificial hip or knee joint recipients. The ReMove-It project uses videos in which a therapist performs the prescribed, personalized exercises, and the patient imitates them in front of a screen at home. If the patient does not comply with the medical guidelines, they receive correction instructions during the performance of the movement. After completing the exercise, the patient receives feedback concerning the quality of performance, and the clinician receives the movement data documented during the exercise. The treating physician, therapist and patient are able to communicate with each other through text, audio and video messages. Fraunhofer plans to offer a device by next year, said Dr. Michael John, one of the Fraunhofer researchers, in a statement. They are also exploring using the system for other diseases that can be treated with exercise therapy, like Parkinson’s disease.
FDA grants de novo request for DreaMed diabetes software
PETAH TIKVA, Israel – The U.S. Food and Drug Administration has granted a de novo request for DreaMed Advisor Pro, an artificial intelligence-based diabetes treatment decision support software designed to assist health care providers in the management of people with Type 1 diabetes who use insulin pumps and continuous glucose monitoring. “This is an innovation that can improve people’s lives and the FDA decision confirms what we believe is an important step in making a more meaningful connection between the health care provider and their Type 1 diabetes patients,” said Eran Atlas, CEO of DreaMed, in a statement. DreaMed Advisor Pro is a cloud-based digital solution generating insulin delivery recommendations by analyzing information from continuous glucose monitoring devices, self-monitoring blood glucose devices and insulin pump data. Applying adaptive learning, Advisor Pro refines its understanding for each individual and sends recommendations to the health care provider on how to optimize a patient’s insulin pump settings for basal rate, carbohydrate ratio and correction factor. Two years ago, in anticipation of the FDA review, DreaMed and diabetes management solutions provider Glooko teamed up to integrate the system into the Glooko diabetes data management platform. “This is a significant achievement and practical example of how AI and digital health can improve patient care and enable care teams,” said Russ Johannesson, CEO of Glooko, in a statement.
NHS partnership to test home urinalysis kit
SALFORD, England – Salford Royal NHS Foundation Trust, in partnership with Healthy.io, has developed a digital home urine testing kit for patients with kidney conditions and will test it through an upcoming project. “This is great news for patients with kidney conditions and we’re really excited to be the first NHS organization to be trying out this smartphone camera testing,” said Dr. Jim Ritchie, consulting kidney physician at Salford Royal NHS Foundation Trust, in a statement. “We’re hoping this will not only make it easier for patients but will empower them to share responsibility for their overall health.” The Salford Royal Virtual Renal Clinic will open to its first 50 patients this month. Using their smartphone cameras and a digital testing kit developed by Healthy.io, patients will be able to test their urine from home and the results will be delivered electronically to their physician in real time. Healthy.io is part of the National Health Service Innovation Accelerator Program, which aims to facilitate and scale innovation across the NHS. “Our goal is to enhance and transform the care patients receive through the use of digital technology,” said Katherine Ward, UK managing director for Healthy.io, in a statement. “Salford Royal is helping lead the charge for improved care through advanced digital technology, and we are proud to partner with them in this initiative.”
Medtronic updates glucose reporting app, partners with Nutrino
DUBLIN – Medtronic has rolled out an updated version of the iPro2 myLog app for clinics to import patient logged data during their professional iPro2 continuous glucose monitoring evaluation. The app now includes Nutrino’s artificial intelligence-powered FoodPrint report technology, enabling clinicians to see food information the patient has logged. With the addition of the FoodPrint report, patients’ meals are graded based on their body’s unique glucose reaction, making it easy for them to understand the link between meals and glucose variability. “By making it easier to communicate relevant, personal insights about food’s impact on diabetes, Medtronic arms physicians and diabetes educators with a powerful coaching tool that will help drive positive behavior change,” said Sheri Dodd, vice president and general manager for non-intensive diabetes therapies at Medtronic, in a statement. “Our partnership with Nutrino to infuse more detail about diet’s impact on glucose furthers our goal to make glucose a vital sign in the treatment of diabetes.” Medtronic has expanded its partnership with Nutrino to embed food data and FoodPrint insights across all the company’s Diabetes Group.
JMI Equity invests in CipherHealth
NEW YORK – Patient communication, engagement and care coordination software company CipherHealth has received a significant strategic growth investment from JMI Equity, a growth equity firm focused on investing in leading software companies. The $37.6 million investment was listed in a recent SEC filing. “We’re excited to partner with JMI and leverage their expertise and industry network to continue to grow and expand,” said Randy Cheung, co-founder and CEO of CipherHealth, in a statement. “JMI has a successful track record of supporting high-growth SaaS companies, and we are thrilled that they are joining us on our journey as we accelerate our growth and deliver the most comprehensive and integrated engagement platform available in healthcare.” The company’s software focuses on patient communication needs from pre-arrival education to follow-up care. “CipherHealth’s solutions are pioneering more effective ways for healthcare providers to engage with their patients, driving improved clinical outcomes and patient experience,” said Matt Emery, general partner at JMI, who will join the board of Cipher Health, in a statement. “We look forward to partnering with CipherHealth as the team continues to innovate at the forefront of patient-centric care.”
Wearable device might detect lung inflammation in cancer patients
PHILADELPHIA – Researchers at the Sidney Kimmel Cancer Center are exploring whether or not a wearable device can detect radiation pneumonitis in lung cancer patients. The condition is a common side effect of radiation therapy and often does not show up until weeks or months after treatment ends. Diagnosis and treatment of the condition is primarily dependent on patients reporting symptoms, but researchers at the center, which is part of Jefferson Health, have begun a clinical trial on the device that collects symptom-related data for early detection and treatment of the condition. Originally designed to monitor breathing in asthma patients, the flat, 3-inch, triangular-shaped patch called ADAMM (Automated Device for Asthma Monitoring and Management) measures biometrics related to breathing, like respiration rate, wheezing, heart rate and temperature. In addition to data collected from ADAMM, patients will also describe any side effects they experience, which in some patients can appear during the treatment, as well. “Ultimately, we hope to evaluate whether this approach could be used to improve patient outcomes and spot an issue before it becomes a serious problem,” said Dr. Adam Dicker, one of the researchers, in a statement. “Health care is on the brink of remarkable change, and the foundation of this change is rooted in the universe of digital—everything from the Internet of Things to computational computing, big data and more.”
Omada adds obesity-related diabetes, hypertension to offerings
SAN FRANCISCO – Omada Health, a digital behavioral counseling program focusing on chronic diseases in employer and health plan populations, has launched two programs to help people with obesity related chronic conditions like diabetes and hypertension. In addition to new condition management programs, Omada is adding features for medication adherence and integrating remote monitoring for glucose and blood pressure. “Omada delivers evidence-based behavior change by combining digitally enabled coaching and clinical fidelity with sophisticated data science,” said Dr. Carolyn Bradner, vice president of medical affairs at Omada, in a statement. “We will now bring that expertise to the challenging areas of medication adherence and remote monitoring through an extensible, flexible platform that treats the whole person, not just a single piece of their diagnosis.”
Masimo, Thermomedics introduce Bluetooth thermometer
IRVINE, Calif., & DELRAY BEACH, Fla., – Masimo and Thermomedics have released a non-contact Bluetooth-enabled thermometer that integrates with the Masimo Root patient monitoring and connectivity platform. “This thermometer makes it easy to efficiently take the temperatures of multiple patients without having to manually record data,” said Joe Kiani, founder and CEO of Masimo, in a statement. “We’re delighted to have partnered with Thermomedics to develop an additional, easy-to-use thermometry option for Root customers.” TIR-1 is a clinical-grade infrared thermometer that provides forehead temperature measurements across all patient populations. Bluetooth connectivity enables wireless data transfer to a connected Root monitor. Masimo Root is a an expandable patient monitoring and connectivity hub that integrates an array of technologies, devices and systems to provide multimodal monitoring and connectivity solutions in a single, clinician-centric platform. “Our team worked diligently to develop the TIR-1, the first Bluetooth-wireless non-contact thermometer to be paired with a vital signs monitoring system,” said William Caragol, chairman and CEO of PositiveID, which owns Thermomedics, in a statement. “We are very proud to bring this product to market with a world-class company like Masimo and introduce non-contact thermometry to the Root platform.”
Purdue researchers develop glucose-monitoring contact lens
WEST LAFAYETTE, Ind. – Researchers at Purdue University have developed soft contact lenses that can monitor glucose, as well as correct vision. “We developed a very unique technology that enables the integration of thin film sensors with a commercially available soft contact lens,” said Chi Hwan Lee, one of the researchers, said in a statement. “These current hydrogel-based contacts serve as the perfect platform for smart lens systems due to their high degree of comfort, biocompatibility, breathability and long-term wearability.” The sensors embedded on the soft contact lens continuously detect the levels of glucose, lactate and pH value, which could help provide information for patients with diabetes, hypoxia and underlying ocular tissue health.
Voluntis, Monarch Medical partner to offer insulin dosing from hospital to home
CAMBRIDGE, Mass.and CHARLOTTE, N.C.– Digital therapeutics company Voluntis is teaming with glucose management company Monarch Medical Technologies to develop strategies aimed at improving the coordination of glycemic management for patients with insulin dosing recommendations in both the inpatient and outpatient setting.
The objective in combining the power of these two systems is to take patients from successful insulin dosing in the hospital, using Monarch’s EndoTool Glucose Management System, to continued effective insulin treatment at home, using Voluntis’ Insulia automated insulin dosing and coaching for daily follow-up.”With both EndoTool and Insulia, providers can be confident that their patients continue to receive personalized dosing recommendations at home, to achieve and maintain target glucose levels,” said Pierre Leurent, CEO and cofounder of Voluntis, in a statement.
One Drop introduces new features for diabetes management
NEW YORK– One Drop, a provider of digital therapeutics solutions for people with diabetes, has launched new features including blood glucose prediction and automated decision support. “The only way to get quality care and support to 500 million people is by developing inexpensive technology that gives each user exactly the support he or she needs, when it’s needed,” said Dr. Dan Goldner, vice president of data science operations at One Drop, in a statement. “That’s One Drop.”
Through the new features, the One Drop mobile app will provide users with blood glucose forecasts up to 12 hours into the future and behavioral recommendations based on those forecasts. Through One Drop’s predictive analytic capabilities, people with diabetes will now be able to receive actionable insights into how their behavior affects their blood glucose levels, without any intervention from a health care provider. The app will display insights for the user as they become relevant. Blood glucose predictions and automated decision support will launch for people with Type 2 diabetes who are not on insulin within 90 days; for insulin users, these features are expected to launch soon after that. Population-level insights gathered from the machine learning models will also support One Drop’s digitally-delivered coaching programs: One Drop Experts, a digitally-delivered diabetes education and coaching program recognized by the American Diabetes Association; and One Drop Revive, a new digitally-delivered diabetes prevention program expected to launch later this year.
HMC HealthWorks to offer CoreHealth platform for members
JUPITER, Fla.– Population health management company HMC HealthWorks has chosen corporate wellness technology provider CoreHealth Technologies and its corporate wellness platform to create an intuitive, enhanced user interface experience, including full mobile capabilities, for plan participants in HMC HealthWorks wellness programs. “HMC is an ideal customer for CoreHealth as they offer a cross-section of wellness programs such as health assessments, health coaching, challenges and more that can truly leverage all that our platform has to offer,” said Anne Marie Kirby, CEO of CoreHealth, in a statement. “Their level of program sophistication demands a flexible and configurable technology that enables them to deliver programs that can be fully adaptable to the unique needs of each of their clients.”
AMA sets guidance for augmented intelligence in health care
CHICAGO – The American Medical Association has released a set of recommendations on augmented intelligence, a technology it says is designed to enhance human intelligence, not replace it.
“The promise of augmented intelligence in spurring technological innovation in medicine has generated growing interest among health care stakeholders,” said Dr. Jesse Ehrenfeld, AMA board member, in a statement. “It also has spurred a range of concerns about the novel challenges in the design, implementation and use—especially how AI will be incorporated into the practice of medicine and affect patients.”
The recommendations state the AMA will: leverage its ongoing engagement in digital health and other priority areas for improving patient outcomes and physicians’ professional satisfaction to help set priorities for health care AI; identify opportunities to integrate the perspective of practicing physicians into the development, design, validation and implementation of health care AI; promote development of thoughtfully designed, high-quality, clinically validated health care AI; encourage education for patients, physicians, medical students, other health care professionals and health administrators to promote greater understanding of the promise and limitations of health care AI; and explore the legal implications of health care AI.
The recommendations stress that AI systems need to be developed and evaluated in keeping with best practices in user-centered design, and usability should be tested by participants who are demographically representative of end users.
“As technology continues to advance and evolve, we have a unique opportunity to ensure that augmented intelligence is used to benefit patients, physicians and the broad health care community,” said Ehrenfeld. “Combining AI methods and systems with an irreplaceable human clinician can advance the delivery of care in a way that outperforms what either can do alone. But we must forthrightly address challenges in the design, evaluation and implementation as this technology is increasingly integrated into physicians’ delivery of care to patients.”
Physicians see mHealth improving patient safety and outcomes, survey finds
TAMPA, Fla. – More than 90% of physicians and hospital leaders believe mobile health technology is improving patient safety and outcomes, according to a recent survey by Black Book Market Research.
The survey also found that secure texting is rapidly developing into the first choice to send information, while keeping sensitive data secured.
Almost 800 hospital-based users and 1,279 physician practices replied to the Black Book survey, which was conducted in Q4 of 2017 and Q1 of 2018.
Sixty three percent of respondents reported ongoing challenges with buy-in of general mobile adoption strategies and related enterprise technology execution, but 85% of hospitals and 83% of physician practices are engaging secure communication platforms between care teams, patients and families.
“When relying on cloud services and third-party servers to manage and route messages, end-to-end encryption that reflects HIPAA’s privacy and security requirements exchanging health data are safeguarding against breaches,” said Doug Brown, president of Black Book Market Research, in a statement.
Nearly all hospitals are budgeting and/or are investing in comprehensive clinical communication platforms before the close of 2018, the survey found.
“Stakeholders across the health care industry are in the quest of finding solutions to use comprehensive real-time data and connectivity cleverly to advance patient safety, productivity and profitability,” said Brown. “Organizations are adopting secure text messaging platforms, as well, because texts are convenient.”
TripleCare expands partnership with Marquis Health Services
NEW YORK – TripleCare has expanded its telehealth services to two Marquis Health locations, a provider of sub-acute rehabilitation and skilled nursing care to patients in New England and the Mid-Atlantic region of the U.S.
TripleCare is bringing its virtual physician care and services to Blueberry Hill Rehabilitation and Healthcare Center in Beverly, Mass., and Oakland Rehabilitation and Healthcare Center in Oakland, N.J.
TripleCare uses a network of experienced physicians who use technology to connect to patients at skille- nursing facilities during the weekends and on holidays, when physician staffing is more limited. By offering full physician accessibility and support during these times, TripleCare’s services are intended to treat patients in place and aid in reducing hospital transfers.
TripleCare combines its physician expertise and technology with support from local, on-site nurses at both Marquis facilities, and employs its telehealth-based protocols to perform bedside exams, in real time. The company’s virtual services make it possible for its physicians to diagnose and determine whether a patient should be treated at the facility or transferred to a hospital.
“Our mission is to help our clients reduce or avoid hospitalizations and readmissions, and with our physician connectivity, we bring facilities and their patients comfort in knowing they can achieve this,” said Dr. Mary Jo Gorman, CEO of TripleCare, in a statement.
Webster Park Rehabilitation and Healthcare Center in Rockland, Mass., another Marquis Health Services location, is scheduled to launch TripleCare’s telehealth services in the third quarter of 2018.